Lassa fever vaccine for deadly virus within reach after ‘promising’ trial results - About 300,000 Lassa fever infections ...
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health, or CVD, ...
Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging ...
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...
The interim analysis shows that the vaccine was safe, well-tolerated and induced robust immune responses against both the rabies virus and Lassa fever vaccine (LASV) in healthy adults.
Interim trial results showed vaccine to be safe and induced immune responses against Lassa virus and rabies virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results